Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
July 10, 2013
A mechanistic, model-based approach to safety assessment in clinical development
J Lippert, M Brosch, O von Kampen, et al.
Haematologica
|
August 11, 2019
Phosphorylation of BECLIN-1 by BCR-ABL suppresses autophagy in chronic myeloid leukemia
Chuanjiang Yu, Sivahari P Gorantla, Alina Müller-Rudorf, et al.
Cardiovascular and Interventional Radiology
|
June 1, 2012
Extrahepatic pseudoaneurysms and ruptures of the hepatic artery in liver transplant recipients: endovascular management and a new iatrogenic etiology
Wael E A Saad, Niloy Dasgupta, Allison J Lippert, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
June 17, 2021
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study
Barbara Mühlemann, Charlotte Thibeault, David Hillus, et al.
ESMO Open
|
February 6, 2026
Mismatch repair deficiency and microsatellite instability in adrenocortical carcinoma
B Altieri, S Kircher, S Herterich, et al.
Infection
|
April 14, 2022
Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study
Tilman Lingscheid, Lena J Lippert, David Hillus, et al.
Journal of Global Antimicrobial Resistance
|
December 26, 2022
Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial
Florian Kurth, Elisa T Helbig, Lena J Lippert, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 13, 2016
Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation
, S F Marshall, R Burghaus, et al.
JCI Insight
|
March 7, 2023
Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19
Charlotte Thibeault, Lara Bardtke, Kanika Vanshylla, et al.
Antonie Van Leeuwenhoek
|
August 3, 2022
Vibrio tetraodonis subsp. pristinus subsp. nov., isolated from the coral Acropora cytherea at Palmyra Atoll, and creation and emended description of Vibrio tetraodonis subsp. tetraodonis subsp. nov
Rachel M Loughran, Sarah A Emsley, Tori Jefferson, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
CPT: Pharmacometrics & Systems Pharmacology
|
July 10, 2013
A mechanistic, model-based approach to safety assessment in clinical development
J Lippert, M Brosch, O von Kampen, et al.
Haematologica
|
August 11, 2019
Phosphorylation of BECLIN-1 by BCR-ABL suppresses autophagy in chronic myeloid leukemia
Chuanjiang Yu, Sivahari P Gorantla, Alina Müller-Rudorf, et al.
Cardiovascular and Interventional Radiology
|
June 1, 2012
Extrahepatic pseudoaneurysms and ruptures of the hepatic artery in liver transplant recipients: endovascular management and a new iatrogenic etiology
Wael E A Saad, Niloy Dasgupta, Allison J Lippert, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
June 17, 2021
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study
Barbara Mühlemann, Charlotte Thibeault, David Hillus, et al.
ESMO Open
|
February 6, 2026
Mismatch repair deficiency and microsatellite instability in adrenocortical carcinoma
B Altieri, S Kircher, S Herterich, et al.
Infection
|
April 14, 2022
Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study
Tilman Lingscheid, Lena J Lippert, David Hillus, et al.
Journal of Global Antimicrobial Resistance
|
December 26, 2022
Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial
Florian Kurth, Elisa T Helbig, Lena J Lippert, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 13, 2016
Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation
, S F Marshall, R Burghaus, et al.
JCI Insight
|
March 7, 2023
Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19
Charlotte Thibeault, Lara Bardtke, Kanika Vanshylla, et al.
Antonie Van Leeuwenhoek
|
August 3, 2022
Vibrio tetraodonis subsp. pristinus subsp. nov., isolated from the coral Acropora cytherea at Palmyra Atoll, and creation and emended description of Vibrio tetraodonis subsp. tetraodonis subsp. nov
Rachel M Loughran, Sarah A Emsley, Tori Jefferson, et al.
Page
of 9